Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of oleanolic acid in pharmacy

A kind of technology of oleanolic acid and medicine, applied in the application field of oleanolic acid in pharmacy

Inactive Publication Date: 2012-08-15
SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, the role of oleanolic acid in inhibiting the activation of renal fibroblasts and mesangial cells, reducing urinary protein in UUO model and Platt model rats (24h urine protein quantification, α1-MG, NAG, β2-MG, TRF), Renal function (Scr, BUN), reducing renal inflammation and collagen deposition, and improving renal fibrosis-related genes and proteins (TGF-β1, CTGF, Collagen III, LN, Collagen I, FN) have not yet been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of oleanolic acid in pharmacy
  • Application of oleanolic acid in pharmacy
  • Application of oleanolic acid in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0119] The oleanolic acid of the present invention is made into tablets according to methods known to those skilled in the art. Oleanolic acid tablets, each containing 50mg of oleanolic acid, 60mg of microcrystalline cellulose, 20mg of micronized silica gel, 10mg of lactose, and 0.7mg of magnesium stearate. Usage: 1 tablet each time, 2-3 times a day, 5-6 days a week, every 3-4 weeks as a course of treatment.

Embodiment 2

[0121] The oleanolic acid of the present invention is prepared into capsules according to methods known to those skilled in the art. Oleanolic acid capsules, each containing 50mg of oleanolic acid. Usage: 1 capsule each time, 2-3 times a day, 5-6 days a week, every 3-4 weeks as a course of treatment.

Embodiment 3

[0123] The oleanolic acid of the present invention is prepared into granules according to methods known to those skilled in the art. Oleanolic acid granules, each bag contains 50mg of oleanolic acid, 60mg of microcrystalline cellulose, 20mg of micronized silica gel, 0.7mg of stearic acid, and 20mg of lactose. Usage: 1 bag each time, 2-3 times a day, 5-6 days a week, every 3-4 weeks as a course of treatment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of oleanolic acid in pharmacy, and relates to the application of the oleanolic acid in the preparation of the medicine for restraining the activation of kidney fibroblast and mesangial cell, the medicine for deducing the kidney fibroblast, the medicine for improving the urine protein, the medicine for improving the kidney function, the medicine for reducing the kidney inflammation and the collagen deposition, and the medicine for reducing gene and protein related to the index of the kidney fibrosis. The invention designs a screening platform for the activation of the TGF (transforming growth factor)-beta 1-induced rat kidney fibroblast and mesangial cell, and discovers that the oleanolic acid with 4.56*10<-5>g / ml-4.56*10<-6>g / ml can restrain the activation of the TGF-beta 1-induced rat kidney fibroblast and mesangial cell. The invention further designs an in-vivo experiment of the oleanolic acid to UUO (unilateral ureteral obstruction) model rat and Platt model rat, and discovers that the oleanolic acid with the middle dose (6mg / kg / d) and the high dose (7mg / kg / d) can reduce the gene and the protein related to the urine protein, the kidney function and the kidney fibrosis of the UUO model rat and the Platt model rat.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine and relates to the use of oleanolic acid, in particular to the application of oleanolic acid in pharmacy. Background technique [0002] Renal fibrosis, characterized by glomerulosclerosis and tubulointerstitial fibrosis, is the final outcome of many chronic kidney diseases. Essentially, renal fibrosis is a process characterized by excessive accumulation and deposition of extracellular matrix. Activation of matrix-producing cells is key to the development of renal fibrosis. Under physiological conditions, fibroblasts produce an appropriate amount of collagen matrix to fill the space between nephrons, blood vessels and the renal capsule. The volume of the kidney gradually increases with age, and fibroblasts mainly play a role in remodeling the renal interstitium. When injury and inflammatory factors persist, fibroblasts proliferate and produce excess extracellular matrix. Newly synthe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/56A61P13/12
Inventor 何立群王东杨雪军王琛林日阳
Owner SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products